Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Diosgenin hemihydrate.

ABSTRACT: Diosgenin [or (22R,25R)-spirost-5-en-3?-ol] is the starting material of the Marker degradation, a cheap semi-synthesis of progesterone, which has been designated as an Inter-national Historic Chemical Landmark. Thus far, a single X-ray structure for diosgenin is known, namely its dimethyl sulfoxide solvate [Zhang et al. (2005 ?). Acta Cryst. E61, o2324-o2325]. We have now determined the structure of the hemihydrate, C(27)H(42)O(3)·0.5H(2)O. The asymmetric unit contains two diosgenin mol-ecules, with quite similar conformations, and one water mol-ecule. Hy-droxy groups in steroids and water mol-ecules form O-H?O hydrogen-bonded R(5) (4)(10) ring motifs. Fused edge-sharing R(10) rings form a backbone oriented along [100], which aggregates the diosgenin mol-ecules in the crystal structure.

SUBMITTER: Hernandez Linares MG

PROVIDER: S-EPMC3414290 | biostudies-other | 2012 Aug

REPOSITORIES: biostudies-other

ACCESS DATA

Json Xml

Publications

Diosgenin hemihydrate.

Hernández Linares María-Guadalupe MG Bernès Sylvain S Flores-Alamo Marcos M Guerrero-Luna Gabriel G Martínez-Gallegos Anselmo A AA

Acta crystallographica. Section E, Structure reports online 20120707 Pt 8

Diosgenin [or (22R,25R)-spirost-5-en-3β-ol] is the starting material of the Marker degradation, a cheap semi-synthesis of progesterone, which has been designated as an Inter-national Historic Chemical Landmark. Thus far, a single X-ray structure for diosgenin is known, namely its dimethyl sulfoxide solvate [Zhang et al. (2005 ▶). Acta Cryst. E61, o2324-o2325]. We have now determined the structure of the hemihydrate, C(27)H(42)O(3)·0.5H(2)O. The asymmetric unit contains two diosgenin mol-ecules, ...[more]

PMID: 22904823

Similar Datasets

Diosgenin supplementation effect on liver

Project description:Expression profile of liver of ICR mice (13-week old) treated with control diet (CRF-1) or CRF-1 containing 500 ppm diosgenin for 4 weeks.

2010-10-08 | GSE24580 | GEO

Tuberostemoamide hemihydrate.

Project description:In the crystal structure of the title compound {systematic name: (1'S,2R,2'R,3'S,6'R)-3'-ethyl-4-methyl-5H-5'-oxa-10'-aza-spiro-[furan-2,4'-tricyclo-[8.3.0.0(2,6)]trideca-ne]-5,11'-dione hemihydrate}, C(17)H(23)NO(4)·0.5H(2)O, the asymmetric unit contains two mol-ecules of tuberostemoamide with similar conformations and one water mol-ecule. The tuberostemoamide mol-ecule is composed of one seven-membered ring (A) and three five-membered rings (B, C and D). Ring A exists in a chair conformation, both rings B and C exist in envelope conformations, and ring D is almost planar with a mean deviation of 0.0143?(4)?Å in one molecule and 0.0095?(3)?Å in the other.. The dihedral angles between the planes of rings C and D are 75.1?(3)° in one mol-ecule and 74.5?(3)° for the other. The solvent water mol-ecule links the tuberostemoamide mol-ecules through O-H?O(ketone) hydrogen bonds. Weak C-H?O inter-actions are also present, involving both the water mol-ecule and a heterocyclic ether O-atom acceptor.

| S-EPMC3247448 | biostudies-literature

5-Bromo-phthalazine hemihydrate.

Project description:The title compound, C(8)H(5)BrN(2)·0.5H(2)O, is a phthalazine derivative synthesized from 3-bromo-benzene-1,2-dicarbaldehyde and hydrazine. The mol-ecule is essentially planar, the deviation from the mean plane of the phthalazine ring being 0.015?(3)?Å. The O atom of the solvent water mol-ecule is situated on a twofold rotation axis. In the crystal, O-H?N hydrogen bonds and short N?Br [2.980?(3)?Å] contacts lead to the formation of a two-dimensional network parallel to (101).

| S-EPMC3414339 | biostudies-literature

Diosgenin supplementation effect on liver

Project description:Expression profile of liver of ICR mice (13-week old) treated with control diet (CRF-1) or CRF-1 containing 500 ppm diosgenin for 4 weeks. Nine-week old ICR mice were fed with a basal diet (CRF-1) or that containing 500 ppm diosgenin for 4 weeks ad libitum (n = 3 in each group). Food intake and body weight were measured on a weekly basis for the duration of the study.

2010-10-08 | E-GEOD-24580 | biostudies-arrayexpress

Diosgenin Loaded Polymeric Nanoparticles with Potential Anticancer Efficacy.

Project description:This study aims to determine the anticancer efficacy of diosgenin encapsulated poly-glycerol malate co-dodecanedioate (PGMD) nanoparticles. Diosgenin loaded PGMD nanoparticles (variants 7:3 and 6:4) were synthesized by the nanoprecipitation method. The synthesis of PGMD nanoparticles was systematically optimized employing the Box-Behnken design and taking into account the influence of various independent variables such as concentrations of each PGMD, diosgenin and PF-68 on the responses such as size and PDI of the particles. Mathematical modeling was done using the Quadratic second order modeling method and response surface analysis was undertaken to elucidate the factor-response relationship. The obtained size of PGMD 7:3 and PGMD 6:4 nanoparticles were 133.6 nm and 121.4 nm, respectively, as measured through dynamic light scattering (DLS). The entrapment efficiency was in the range of 77-83%. The in vitro drug release studies showed diffusion and dissolution controlled drug release pattern following Korsmeyer-Peppas kinetic model. Furthermore, in vitro morphological and cytotoxic studies were performed to evaluate the toxicity of synthesized drug loaded nanoparticles in model cell lines. The IC50 after 48 h was observed to be 27.14 µM, 15.15 µM and 13.91 µM for free diosgenin, PGMD 7:3 and PGMD 6:4 nanoparticles, respectively, when administered in A549 lung carcinoma cell lines.

| S-EPMC7765552 | biostudies-literature

4-Pheneth-oxy-aniline hemihydrate.

Project description:The crystal structure of the title compound, C(14)H(15)NO·0.5H(2)O, features N-H?O and O-H?N hydrogen bonds between the amino group and water molecule of crystallization, which generate a chain along the c axis. The water mol-ecule lies on a twofold rotation axis. A C-H?? inter-action is observed between the phenyl and aniline rings. The angle between the mean planes of the phenyl rings is 72.51?(7)°.

| S-EPMC3379468 | biostudies-literature

Allyl-ammonium hydrogen oxalate hemihydrate.

Project description:In the title hydrated mol-ecular salt, C3H8N(+)·C2HO4 (-)·0.5H2O, the water O atom lies on a crystallographic twofold axis. The C=C-C-N torsion angle in the cation is 2.8?(3)° and the dihedral angle between the CO2 and CO2H planes in the anion is 1.0?(4)°. In the crystal, the hydrogen oxalate ions are linked by O-H?O hydrogen bonds, generating [010] chains. The allyl-ammonium cations bond to the chains through N-H?O and N-H?(O,O) hydrogen bonds. The water mol-ecule accepts two N-H?O hydrogen bonds and makes two O-H?O hydrogen bonds. Together, the hydrogen bonds generate (100) sheets.

| S-EPMC4158551 | biostudies-literature

4-Carbamoylpiperidinium phenyl-acetate hemihydrate.

Project description:The asymmetric unit of the title compound, C(6)H(13)N(2)O(+)·C(8)H(7)O(2) (-)·0.5H(2)O, comprises two isonipecotamide cations, two phenyl-acetate anions and a water mol-ecule of solvation. The hydrogen-bonding environments for both sets of ion pairs are essentially identical with the piperidinium and amide 'ends' of each cation involved in lateral heteromolecular hydrogen-bonded cyclic N-H?O associations [graph set R(2) (2)(11)] which incorporate a single carboxyl O-atom acceptor. These cyclic motifs enclose larger R(5) (5)(21) cyclic systems, forming sheet substructures which lie parallel to (101) and are linked across b by the single water mol-ecule via water O-H?O(c) (c = carboxylate) associations, giving a duplex-sheet structure.

| S-EPMC3011685 | biostudies-literature

tert-Butyl-dimethyl-silanol hemihydrate.

Project description:The crystal structure of the title compound, C(6)H(16)OSi·0.5H(2)O, reveals an asymmetric unit containing two mol-ecules of the silanol and a single water mol-ecule. There is evidence of hydrogen bonding between the three mol-ecules in the asymmetric unit. The H atoms of the silanol OH groups and the water H atoms are each disordered equally over two positions.

| S-EPMC2961358 | biostudies-literature

Synthesis and Pharmacological Effects of Diosgenin-Betulinic Acid Conjugates.

Project description:The target diosgenin-betulinic acid conjugates are reported to investigate their ability to enhance and modify the pharmacological effects of their components. The detailed synthetic procedure that includes copper(I)-catalyzed Huisgen 1,3-dipolar cycloaddition (click reaction), and palladium-catalyzed debenzylation by hydrogenolysis is described together with the results of cytotoxicity screening tests. Palladium-catalyzed debenzylation reaction of benzyl ester intermediates was the key step in this synthetic procedure due to the simultaneous presence of a 1,4-disubstituted 1,2,3-triazole ring in the molecule that was a competing coordination site for the palladium catalyst. High pressure (130 kPa) palladium-catalyzed procedure represented a successful synthetic step yielding the required products. The conjugate 7 showed selective cytotoxicity in human T-lymphoblastic leukemia (CEM) cancer cells (IC50 = 6.5 ± 1.1 µM), in contrast to the conjugate 8 showing no cytotoxicity, and diosgenin (1), an adaptogen, for which a potential to be active on central nervous system was calculated in silico. In addition, 5 showed medium multifarious cytotoxicity in human T-lymphoblastic leukemia (CEM), human cervical cancer (HeLa), and human colon cancer (HCT 116). Betulinic acid (2) and the intermediates 3 and 4 showed no cytotoxicity in the tested cancer cell lines. The experimental data obtained are supplemented by and compared with the in silico calculated physico-chemical and absorption, distribution, metabolism, and excretion (ADME) parameters of these compounds.

| S-EPMC7435711 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data